| Patents for A61P 9 - Drugs for disorders of the cardiovascular system (159,484) |
|---|
| 01/16/2008 | EP1492793B1 New-4-(pyrrolopyrimidin-6-yl)benzenesulphonamide derivatives |
| 01/16/2008 | EP1392306B1 Substituted tetrahydroisoquinolines for use in the treatment of inflammatory diseases |
| 01/16/2008 | EP1317432B1 Piperidine derivatives for use as 2,3-oxidosqualene-lanosterol cyclase inhibitors |
| 01/16/2008 | EP1315793B1 Methods for culturing human lung mast cells and uses thereof |
| 01/16/2008 | EP1278532B1 Plant extract of the olea europaea species as no-synthase inhibitor and uses |
| 01/16/2008 | EP1204626B1 Ether compounds, compositions, and uses thereof |
| 01/16/2008 | EP1200118B1 A pharmaceutical formulation comprising megalatran and its prodrug |
| 01/16/2008 | EP1198255B1 Identification of compounds that modify transcriptional responses to hypoxia |
| 01/16/2008 | EP1085848B1 Inhibitors of transcription factor nf-kappa b |
| 01/16/2008 | EP1019073B1 Apolipoprotein a-i agonists and their use to treat dyslipidemic disorders |
| 01/16/2008 | CN201006015Y Nitroglycerin pad pasting |
| 01/16/2008 | CN101107259A Silicon compounds and their use |
| 01/16/2008 | CN101107248A 7-{4-[2-(2,6-dichloro-4-methylphenoxy)ethoxy]phenyl}-3,9-diazabicyclo[3.3.31]non-6-ene-6-carboxylic acid cyclopropyl-(2,3-dimethylbenzyl)amide as inhibitors of renin for the treatment of hypertension. |
| 01/16/2008 | CN101106987A Metabolic syndrome-improving agent and medicine, supplement, functional food and food additive containing the same |
| 01/16/2008 | CN101106986A Metabolic syndrome-improving agent and medicine, supplement, functional food and food additive containing the same |
| 01/16/2008 | CN101104649A Potassium alginate and composition thereof |
| 01/16/2008 | CN101104072A Medicine for curing angiocardiopathy and cerebrovascular disease and its preparing method |
| 01/16/2008 | CN101104067A Medicine for treating heart disease and preparation process thereof |
| 01/16/2008 | CN101104063A Traditional Chinese medicine composition for treating apoplexy and hemiplegia |
| 01/16/2008 | CN101104048A Compound medicine for pulse generating and treating coronary heart disease |
| 01/16/2008 | CN101104043A Traditional Chinese medicine dispersion tablet for treating coronary heart disease and angina pectoris and preparing process thereof |
| 01/16/2008 | CN101104030A Blood pressure reducing jujube tea paste for radically treating high blood pressure |
| 01/16/2008 | CN101104029A Medicinal compositions |
| 01/16/2008 | CN101104020A Traditional Chinese medicine decoction for treating hemorrhoid |
| 01/16/2008 | CN101104019A Traditional Chinese medicine preparation for treating coronary heart disease and angina pectoris and its preparing process |
| 01/16/2008 | CN101104017A Sanwu pellet and its preparing process |
| 01/16/2008 | CN101104016A Oral solid preparation of corydalis and its new use |
| 01/16/2008 | CN101104015A Olive soft capsule raw material formulation and its preparation technology |
| 01/16/2008 | CN101104012A Medicine for treating cardiovascular disease |
| 01/16/2008 | CN101104010A Extracting and purifying technology for haw flavonoids substances |
| 01/16/2008 | CN101103985A Folic acid dropping pill and its preparation method |
| 01/16/2008 | CN101103983A Medicinal composition stabilized by base reagent containing pitavastatin calcium and preparation technology thereof |
| 01/16/2008 | CN101103979A Azelnidipine medicinal composition and its preparing method |
| 01/16/2008 | CN101103967A Medicine composition containing bevantolol hydrochloride |
| 01/16/2008 | CN101103966A Omega-3 falty acid-garlic oil capsule and manufacturing method thereof |
| 01/16/2008 | CN101103964A Sustained-release preparation containing felodipine and preparation method thereof |
| 01/16/2008 | CN101103962A Vinpocetine oral self-micro-emulsification medicine-releasing system and preparation method thereof |
| 01/16/2008 | CN101103752A Bamboo charcoal bag health-care tea |
| 01/16/2008 | CN100362014C 17-hydroxy C27 steroid compound and its synthesis and use |
| 01/16/2008 | CN100362011C Preparation method of ginkgo leaf extract |
| 01/16/2008 | CN100361943C 2-(butyl-1-sulfonylamino)-n-[1(r)-(6-methoxypyridin-3-yl)propyl] benzamide, its use as a medicament, and pharmaceutical preparations comprising it |
| 01/16/2008 | CN100361676C Pain stopping ointment for piles |
| 01/16/2008 | CN100361672C Red sage root ligustrazine freeze dried injecta and preparation method thereof |
| 01/16/2008 | CN100361670C Method of extracting polyphenol from pomegranate seed |
| 01/16/2008 | CN100361666C Kudzu vine capsule for regulating blood pressure and blood fat, its preparation process |
| 01/16/2008 | CN100361665C Compositions and methods for treatment of mitochondrial diseases |
| 01/16/2008 | CN100361656C Butylbenzene phthalein self emulsifying releasing medicine system, preparation method and application |
| 01/16/2008 | CN100361649C Prepn process of alive adult roach extract |
| 01/15/2008 | US7319163 N-[3,5-Dibromo-4-(3-bromobenzyloxy)benzoyl]benzenesulphonamide for example; cardiac arrhythmias, thyrotoxicosis and subclinical hyperthyroidism |
| 01/15/2008 | US7319160 Tetrafluorobenzyl derivatives and pharmaceutical composition for preventing and treating acute and chronic neurodegenerative diseases in central nervous system containing the same |
| 01/15/2008 | US7319150 Method for preparing styryl pyrazole, isoxazole and isothiazole derivatives |
| 01/15/2008 | US7319138 Comprises transcription factor referred to as dragon protein (DRG) for treating and diagnosing nervous system, skin, muscle, bone and eye disorders |
| 01/15/2008 | US7319104 hPPARs activators |
| 01/15/2008 | US7319100 1-(1H-Pyrazin-2-on-3-yl)tetrahydroquinolines (3-(8-Bromo-6-methoxy-1,2,3,4-tetrahydroquinoline)-5-chloro-1-(1-ethylpropyl)-2(1H)-pyrazinone); treating anxiety and depression |
| 01/15/2008 | US7319096 Antiarrhythmia agents; liver disorders; skin disorders |
| 01/15/2008 | CA2319763C Cholenic acid amides and pharmaceutical compositions thereof |
| 01/15/2008 | CA2272971C Quinone derivatives for treating or preventing diseases associated with iron overload |
| 01/15/2008 | CA2123405C Angiostatic steroids |
| 01/10/2008 | WO2008006044A2 Substituted acid derivatives useful as antidiabetic and antiobesity agents and method |
| 01/10/2008 | WO2008005348A1 Synthesis of diethyl{ i5' (3 -fluorophenyl) -pyridine-2-yl] methyl} phosphonate used in the synthesis of himbacine analogs |
| 01/10/2008 | WO2008004673A1 Cycloalkene derivatives, process for production of the derivatives, and use of the same |
| 01/10/2008 | WO2008004341A1 α-SUBSTITUTED PHENYLPROPIONIC ACID DERIVATIVES |
| 01/10/2008 | WO2008003753A1 Pyrazolo [1,5-a] pyrimidine analogs for use as inhibitors of stearoyl-coa desaturase (scd) activity |
| 01/10/2008 | WO2008003665A1 Benzimidazole cannabinoid agonists bearing a substituted heterocyclic group |
| 01/10/2008 | WO2008003479A1 Methods, compositions, unit dosage forms, and kits for pharmacologic stress testing with reduced side effects |
| 01/10/2008 | WO2008003424A1 Substituted benzoxepino-isoxazoles and use thereof |
| 01/10/2008 | WO2008003414A1 Aqueous pharmaceutical formulation of 4-[((4-carboxybutyl)-{2-[(4-phenethyl-benzyl)oxy]-phenethyl}amino)methyl] benzoic acid |
| 01/10/2008 | WO2008003141A1 Therapeutic compounds |
| 01/10/2008 | WO2007136680A3 3-pyraz0lyl-benzamide-4-ethers, secondary amines and derivatives thereof as modulators of the 5-ht2a serotonin receptor useful for the treatment of disorders related thereto |
| 01/10/2008 | WO2007134085A3 Isothiazolidines useful in the treatment of ocular hypertensive conditions |
| 01/10/2008 | WO2007130509A3 Pyrroloquinoline quinones and use thereof |
| 01/10/2008 | WO2007122382A3 Lycopene for the treatment of metabolic dysfunction |
| 01/10/2008 | WO2007121921A3 Purine derivatives for use as adenosin a2a receptor agonists |
| 01/10/2008 | WO2007116297A3 Use of aminapthone for the preparation of a medicament for treating arteriophaties |
| 01/10/2008 | WO2007104652A3 Non-peptidic renin inhibitors nitroderivatives |
| 01/10/2008 | WO2007059533A3 Uses for camki i and hdacs in the treatment of heart conditions |
| 01/10/2008 | WO2007050425A3 Lxr modulators |
| 01/10/2008 | WO2007003330A3 Pharmaceutical dosage form containing an active principle combination of nifedipine and/or nisoldipine and of an angiotensin ii antagonist |
| 01/10/2008 | WO2004108056A3 Packing, or kit of medicaments, or facilitating presentation of administering of medicaments on the part of individuals under preventive situation and/or treatment of the atherosclerosis disease |
| 01/10/2008 | US20080009631 e.g. 2-[4-[3-[2-(2,4-Dichlorophenyl)-5-isopropyl-4-oxazolyl]propionyl]-2-methylphenoxy]-2-methylpropionic acid; |
| 01/10/2008 | US20080009531 5-Anilino-4-Heteroarylpyrazole Derivatives Useful for the Treatment of Diabetes |
| 01/10/2008 | US20080009525 Activator of peroxisome proliferator-activated receptor delta |
| 01/10/2008 | US20080009506 Imidazole Compound |
| 01/10/2008 | US20080009503 Method of treating diabetes |
| 01/10/2008 | US20080009498 Phosphodiesterase inhibitors and nitric oxide donors, compositions and methods of use |
| 01/10/2008 | US20080009487 Treatment of athersclerotic disease |
| 01/10/2008 | US20080009485 Methods for the use of inhibitors of cytosolic phospholipase A2 in the treatment of thrombosis |
| 01/10/2008 | US20080009465 Novel glucokinase activators and methods of using same |
| 01/10/2008 | US20080009457 Reaction of Rna and cochleate |
| 01/10/2008 | US20080009453 Pharmceutical Compositions Containing Polydatin or Its Salts and Their Application |
| 01/10/2008 | US20080009442 Therapeutic use for alpha1 proteinase inhibitor in hematopoiesis |
| 01/10/2008 | US20080009441 Polypeptide Inducing the Secretion of Angiopoietin |
| 01/10/2008 | US20080009433 Use of glp-1 or analogs in treatment of myocardial infarction |
| 01/10/2008 | US20080009025 Protein kinase regulation |
| 01/10/2008 | US20080008766 Methods of Repairing Bone |
| 01/10/2008 | US20080008702 Antibody immunization therapy for treatment of atherosclerosis |
| 01/10/2008 | US20080008701 C-met receptor regulation by angiotensin iv (at4) receptor ligands |
| 01/10/2008 | DE102006031176A1 Substituierte Benzoxepino-isoxazole und ihre Verwendung Substituted benzoxepino-isoxazoles and their use |
| 01/10/2008 | DE102006031175A1 Wässrige Arzneimittelformulierung von 4-[((4-Carboxybutyl)-(2[(4-phenethyl-benzyl)oxy]-phenethyl)amino)methyl]benzoesäur An aqueous pharmaceutical formulation of 4 - [((4-carboxybutyl) - (2 [(4-phenethyl-benzyl) oxy] phenethyl) amino) methyl] benzoesäur |
| 01/10/2008 | CA2825491A1 Compositions and methods for preventing or treating cardiovascular diseases in felines with hyperthyroidism |